Som Bioherb Products Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 23-10-2024
- Paid Up Capital ₹ 4.90 M
as on 23-10-2024
- Company Age 15 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.23 Cr
as on 23-10-2024
- Satisfied Charges ₹ 1.95 M
as on 23-10-2024
- Revenue %
(FY 2023)
- Profit 15.58%
(FY 2023)
- Ebitda -16.99%
(FY 2023)
- Net Worth -3.05%
(FY 2023)
- Total Assets -1.13%
(FY 2023)
About Som Bioherb Products
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 4.90 M.
The company currently has active open charges totaling ₹1.23 Cr. The company has closed loans amounting to ₹1.95 M, as per Ministry of Corporate Affairs (MCA) records.
Yashodhara Verma, Kapil Verma, Ratnesh Verma, and One other member serve as directors at the Company.
- CIN/LLPIN
U01122RJ2009PTC030247
- Company No.
030247
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Nov 2009
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Company Details
- Location
Kota, Rajasthan, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Som Bioherb Products?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kapil Verma  | Director | 13-Nov-2009 | Current |
| Yashodhara Verma | Director | 13-Nov-2009 | Current |
| Ratnesh Verma | Director | 13-Nov-2009 | Current |
| Kamal Verma | Director | 16-Aug-2011 | Current |
Financial Performance of Som Bioherb Products.
Som Bioherb Products Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 15.58% increase in profit. The company's net worth dipped by a decrease of 3.05%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Som Bioherb Products?
In 2023, Som Bioherb Products had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Union Bank Of India Creation Date: 25 May 2012 | ₹1.23 Cr | Open |
Union Bank Of India Creation Date: 05 Sep 2012 | ₹1.95 M | Satisfied |
How Many Employees Work at Som Bioherb Products?
Unlock and access historical data on people associated with Som Bioherb Products, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Som Bioherb Products, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Som Bioherb Products's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
